Evaluation of nasal and oropharyngeal flora in patients with acne vulgaris according to treatment options

International Journal of Dermatology

Volumn 53, Issue 11, 2014, Pages 1404-1408

  Ozuguz, Pinar ^a   Callioglu, Elif E ^b   Tulaci, Kamil G ^b   Kacar, Seval D ^a   Balta, Ilknur ^c   Asik, Gulsah ^a   Karatas, Serap ^a   Karaca, Semsettin ^a  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Department of Cardiology   (Turkey)

^c Department of Pediatrics   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; METICILLIN; TETRACYCLINE; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT;

ACNE VULGARIS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROFLORA; NOSE; NOSE CAVITY; NOSE SMEAR; OROPHARYNX; STAPHYLOCOCCUS AUREUS; SYSTEMIC THERAPY; THROAT CULTURE; TOPICAL TREATMENT; TREATMENT DURATION; TURKEY (REPUBLIC); ADOLESCENT; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; MICROBIOTA; NASAL CAVITY; OROPHARYNX; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; TETRACYCLINE; YOUNG ADULT;

EID: 84911968091     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12537     Document Type: Article

References (25)

1. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364: 2188-2195.
2. Tripathi SV, Gustafson CJ, Huang KE, et al. Side effects of common acne treatments. Expert Opin Drug Saf 2013; 12: 39-51.
3. Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol 2008; 158: 208-216.
4. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60(Suppl. 5): S1-S50.
5. Mills O Jr, Thornsberry C, Cardin CW, et al. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol 2002; 82: 260-265.
6. Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41-45.
7. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance - a perspective: report of Task Force 6. Rev Infect Dis 1987; 9: 297-312.
8. Weissmann A, Wagner A, Plewig G. Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis retinoic acid. Arch Dermatol Res 1981; 270: 179-183.
9. James WD, Leyden JJ. Treatment of gram-negative folliculitis with isotretinoin: positive clinical and microbiologic response. J Am Acad Dermatol 1985; 1: 319-324.
10. Mobbs KJ, van Saene HKF, Sunderland D, et al. Oropharyngeal gram negative bacillary carriage. Chest 1999; 115: 1570-1575.
11. Sveinbjörnsdottir S, Gudmundsson S, Briem H. Oropharyngeal colonization in the elderly. Eur J Clin Microbiol Infect Dis 1991; 10: 959-963.
12. Willey J, Sherwood L, Woolverton C. Prescott's Microbiology, 8th edn. New York: McGraw-Hill, 2011: 731-737.
13. http://www.dermatologyinfo.net/english/chapters/chapter06.htm (Accessed August 17 2013).
14. Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol 1987; 123: 606-608.
15. Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986; 86: 390-393.
16. Eady EA, Cove JH, Blake J, et al. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988; 118: 415-423.
17. Levy RM, Huang EY, Roling D, et al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003; 139: 467-471.
18. Miller YW, Eady EA, Lacey RW, et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996; 38: 829-837.
19. Fanelli M, Kupperman E, Lautenbach E, et al. Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol 2011; 147: 917-921.
20. Marples RR, Fulton JE Jr, Leyden J. Effects of antibiotics on the nasal flora in acne patients. Arch Dermatol 1969; 99: 647-651.
21. Neubert U, Jansen T, Plewig G. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. Int J Dermatol 1999; 38: 270-274.
22. Scherer A, Vogt HR, Vilei EM, et al. Enhanced antibiotic multi-resistance in nasal and faecal bacteria after agricultural use of streptomycin. Environ Microbiol 2013; 15: 297-304.
23. Böni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol 2003; 4: 273-276.
24. Williams RE, Doherty VR, Perkins W, et al. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992; 126: 362-366.
25. Başak PY, Cetin ES, Gürses I, et al. The effects of systemic isotretinoin and antibiotic therapy on the microbial floras in patients with acne vulgaris. J Eur Acad Dermatol Venereol 2013; 27: 332-336.